Carlos E Durán doctoral student, Martín Cañás associate professorcoordinator, Thierry Christiaens professor
Durán C E, Cañás M, Christiaens T.
EMA and FDA decisions based on flawed evidence to approve new cancer drugs negatively affect Latin American patients
BMJ 2019; 367 :l6017
doi:10.1136/bmj.l6017